The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety. Regulation and Deregulation of Industry, Appointments and Executive Changes, Drugs (Pharmaceuticals), Medicine and Health, Eli Lilly and Company, Food and Drug Administration, Health and Human Services Department, Kennedy, Robert F Jr The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety. NYT > Business
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
